Vitamin K2
Vitamin K2 (menaquinone) is the tissue-directing form of vitamin K, distinct from K1 (dietary clotting factor). Its primary role is activating matrix Gla protein (MGP) and osteocalcin — proteins that direct calcium into bone and prevent arterial calcification. K2 deficiency is common (especially with high-dose vitamin D3 supplementation) and correlates with aortic and coronary artery calcification. MK-7 (fermented soy/natto) has a longer half-life and higher bioactivity than MK-4. The Rotterdam Study showed 50μg MK-7/day associated with 57% reduction in aortic calcification progression and 52% reduction in cardiovascular death. Essential companion to vitamin D3.
Evidence
No score yet
Safety
Unknown safety profile
Clinical Status
No formal phase listed
Research Sync
Not synced yet
Dosing
Pharmacology
Evidence Score
Plain-English Snapshot
Vitamin K2 is currently categorized as a vitamin mineral compound.
Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.
Safety scoring is incomplete. Start conservatively and monitor carefully.
Core mechanism
Cofactor for gamma-glutamyl carboxylase; activates MGP (prevents arterial calcification) and osteocalcin (bone mineralization, glucose metabolism)
Practical Context
Strongest current signals
No indexed study summaries yet.
Elevated caution signals
1 severe/high side effect flag